Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Gaiccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopolou P, Kovacs GG, Meyronet D, Marchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichneberger N, Thal DR, BNE consortium, Kretzschmar H (2006) Inter-laboratory comparison of assessments of AD-related lesions. A study of the BrainNet Europe consortium. J Neuropathol Exp Neurol 65 (in press) Alzheimer A (1906) Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurolog Centralbl 23:1129–1136 Alzheimer A (1911) Über eigenartige Krankheitsfälle des späteren Alters. Z ges Neurol Psychiatr 4:356–385 Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1:103–116 Arriagada PV, Growdon J, Hedley-Whyte E, Hyman BT (1992a) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631–639 Arriagada PV, Marzloff K, Hyman BT (1992b) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology 42:1681–1688 Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90–99 Bancher C, Braak H, Fischer P, Jellinger KA (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer’s and Parkinson’s disease patients. Neurosci Lett 162:179–182 Bancher C, Paulus W, Paukner K, Jellinger K (1997) Neuropathologic diagnosis of Alzheimer’s disease: consensus between practicing neuropathologists? Alzheimer Dis Assoc Disord 11:207–219 Beech RH, Davenport HA (1933) The Bielschowsky staining technique. A study of the factors influencing its specificity for nerve fibers. Stain Technol 8:11–30 Bielschowsky M (1902) Die Silberimprägnation der Axenzylinder. Neurol Centralb 13:579–584 Bielschowsky M (1903) Die Silberimprägnation der Neurofibrillen. Neurol Centralb 21:997–1006 Bielschowsky M (1904) Die Silberimprägnation der Neurofibrillen. Einige Bemerkungen zu der von mir angegebenen Methode und den von ihr gelieferten Bildern. J Psychol Neurol 3:169–189 Bielschowsky M (1905) Die Darstellung der Axenzylinder peripherischer Nervenfasern und der Axenzylinder zentraler markhaltiger Nervenfasern. Ein Nachtrag zu der von mir angegebenen Imprägnationsmethode der Neurofibrillen. J Psychol Neurol 4:228–231 Bielschowsky M (1909) Eine Modifikation meines Silberimprägnations-verfahrens zur Darstellung der Neurofibrillen. J Psychol Neurol 12:135–137 Biernat J, Mandelkow EM, Schröter E, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serin-proline motifs upstream of the microtubule binding region. EMBO J 11:1593–1597 Bobinski M, Wegiel J, Tarnawski M, de Leon MJ, Reisberg B, Miller DC, Wisniewski HM (1998) Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res 799:156–158 Bowler JV, Munoz DG, Merskey H, Haschinski V (1998) Fallacies in the pathological confirmation of the diagnosis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 64:18–24 Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567 Braak E, Braak H (1997a) Alzheimer’s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon’s horn. Acta Neuropathol 93:323–325 Braak H, Braak E (1991a) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259 Braak H, Braak E (1991b) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216 Braak H, Braak E (1992) The human entorhinal cortex. Normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6–31 Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 585–613 Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–284 Braak H, Braak E (1997b) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351–357 Braak H, Braak E (1997c) Diagnostic criteria for neuropathologic assessment of Alzheimer’s disease. Neurobiol Aging 18(Suppl 4):85–88 Braak H, Braak E (1999) Temporal sequence of Alzheimer’s disease-related pathology. In: Peters A, Morrison JH (eds) Cerebral cortex, vol 14 Plenum Press, New York, pp 475–512 Braak H, Del Tredici K (2004) Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation. Neurobiol Aging 25:713–718 Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer’s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65:351–355 Braak H, Braak E, Ohm TG, Bohl J (1988) Silver impregnation of Alzheimer’s neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 63:197–200 Braak H, Del Tredici K, Schultz C, Braak E (2000) Vulnerability of select neuronal types to Alzheimer’s disease. In: Khachaturian ZS, Mesulam MM (eds) Alzheimer’s disease. A compendium of current theories. Ann NY Acad Sci 924:53–61 Churukian CJ, Kazee AM, Lapham LW, Eskin TA (1992) Microwave modification of Bielschowsky silver impregnation method for diagnosis of Alzheimer’s disease. J Histotechnol 15:299–302 Cras P, Smith MA, Richey PL, Siedlak SL, Mulvihill P, Perry G (1995) Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer’s disease. Acta Neuropathol 89:291–295 Coleman PD (1997) Research uses of neuropathological data. Neurobiol Aging 18(Suppl 4):97–98 Cullen KM, Halliday GM, Cartwright H, Kril JJ (1996) Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads. Neurodegeneration 5:177–187 Delacourte A, David JP, Dergeant N, Buée L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 52:1158–1165 Dickson DW (1997) The value of cross sectional neuroanatomical studies as a conceptual framework for prospective clinicopathological studies. Neurobiol Aging 18:382–386 Duyckaerts C, Hauw JJ (1997a) Diagnosis and staging of Alzheimer’s disease. Neurobiol Aging 18(Suppl 4):33–42 Duyckaerts C, Hauw JJ (1997b) Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging 18(Suppl 4):362–369 Duyckaerts C, He Y, Seilhean D, Delaère P, Piette F, Braak H, Hauw JJ (1994) Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals. Neurobiol Aging 15(Suppl 1):140–141 Duyckaerts C, Delaère P, He Y, Camilleri S, Braak H, Piette F, Hauw JJ (1995) The relative merits of tau- and amyloid markers in the neuropathology of Alzheimer’s disease. In: Bergener M, Finkel SI (eds) Treating Alzheimer’s and other dementias. Springer, Heidelberg Berlin New York, pp 81–89 Duyckaerts C, Bennecib M, Grignon Y, Piette F, Hauw JJ (1996) Is the topography of Alzheimer’s disease lesions a clue to their pathogenesis? Bull Acad Natl Med 180:1703–1714 Duyckaerts C, Bennecib M, Grignon Y, Uchihara T, He Y, Piette F, Hauw JJ (1997) Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 18(Suppl. 4):267–273 Esiri MM, Hyman BT, Beyreuther K, Masters C (1997) Aging and dementia. In: Graham DL, Lantos PI (eds) Greenfield’s neuropathology. Arnold, London, pp 153–234 Feany MB, Dickson DW (1996) Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol 40:139–148 Fewster PH, Griffin-Brooks S, MacGregor J, Ojalvo-Rose E, Ball MJ (1991) A topographical pathway by which histopathological lesions disseminate through the brain of patients with Alzheimer’s disease. Dementia 2:121–132 Flowers D, Harasty J, Halliday G, Kril J (1996) Microwave modification of the methenamine silver technique for the demonstration of Alzheimer-type pathology. J Histotechnol 19:33–38 Gallyas F (1971) Silver staining of Alzheimer’s neurofibrillary changes by means of physical development. Acta Morph Acad Sci Hung 19:1–8 Gallyas F (1979) Light insensitive physical developers. Stain Technol 54:173–176 Gallyas F, Wolff JR (1986) Metal-catalyzed oxidation renders silver intensification selective. Application for the histochemistry of diaminobenzidine and neurofibrillary changes. J Histochem Cytochem 34:1667–1672 Garvey W, Fathi A, Bigelow F, Jimenez CL, Carpenter BF (1991) Rapid, reliable and economical silver stain for neurofibrillary tangles and senile plaques. J Histotechnol 14:39–42 Geddes JW, Tekirian TL, Soultanian NS, Ashford JW, Davis DG, Markesbery WR (1997) Comparison of neuropathologic criteria for the diagnosis of Alzheimer’s disease. Neurobiol Aging 18(Suppl 4):99–105 Gertz HJ, Xuereb JH, Huppert FA, Brayne C, McGee MA, Paykel ES, Harrington C, Mukaetova-Ladinska E, Arendt T, Wischik CM (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease. Acta Neuropathol 95:154–158 Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci 16:460–465 Goedert M (1999) Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and α-synucleinopathies. Phil Trans R Soc Lond B Biol Sci 354:1101–1108 Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167–169 Goedert M, Trojanowski JQ, Lee VMY (1997) The neurofibrillary pathology of Alzheimer’s disease. In: Rosenberg RN (ed) The molecular and genetic basis of neurological disease. 2nd edn. Butterworth-Heinemann, Boston, pp 613–627 Gold G, Bouras C, Kövari E, Canuto A, González Glaría B, Malky A, Hof PR, Michel JP, Giannakopoulos P (2000) Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 99:579–582 Grober E, Dickson D, Sliwinski MJ, Buschke H, Katz M, Crystal H, Lipton RB (1999) Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20:573–579 Halliday G, Ng T, Rodriguez M, Harding A, Blumbergs P, Evans W, Fabian V, Fryer V, Gonzales M, Harper C, Kalnins R, Masters CL, McLean C, Milder DG, Pamphlett R, Scott G, Tannenberg A., Kril J (2002) Consensus neuropathological diagnosis of common dementia syndromes: testing and standardizing the use of multiple diagnostic criteria. Acta Neuropathol 104:72–78 Harding AJ, Kril JJ, Halliday GM (2000) Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol 99:199–208 Hyman BT (1997) The neuropathological diagnosis of Alzheimer’s disease: clinical-pathological studies. Neurobiol Aging 18(Suppl. 4):27–32 Hyman BT (1998) New neuropathological criteria for Alzheimer’s disease. Arch Neurol 55:1174–1176 Hyman BT, Gomez-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific diasease, not a global brain disease. Neurobiol Aging 15:353–354 Hyman BT, Trojanowski JQ (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097 Iqbal K, Braak E, Braak H, Zaidi T, Grundke-Iqbal I (1991) A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging 12:357–361 Iqbal K, Braak H, Braak E, Grundke-Iqbal I (1993) Silver labeling of Alzheimer neurofibrillary changes and brain β amyloid. J Histotechnol 16:335–342 Jellinger KA (1998) The neuropathological diagnosis of Alzheimer’s disease. J Neural Transm 53(Suppl):97–118 Jellinger K (2000) Clinical validity of Braak staging in the oldest-old. Acta Neuropathol 99:583–584 Jellinger KA, Bancher C (1997) Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer’s disease. Neurobiol Aging 18(Suppl 4):55–65 Kauppinen T, Martikainen P, Alafuzoff I (2006) Human postmortem brain tissue and 2 mm tissue microarrays. Appl Immunohistochem Mol Morphol (in press) Kreutzberg GW, Blakemore WF, Graeber MB (1997) Cellular pathology of the central nervous system. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology. Arnold, London, pp 85–156 Lamy C, Duyckaerts C, Delaère P, Payan C, Fermanian J, Poulain V, Hauw JJ (1989) Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol 15:563–578 Markesbery WR (1997) Neuropathological criteria for the diagnosis of Alzheimer’s disease. Neurobiol Aging 18(Suppl 4):13–19 McKeel DW, Price JL, Miller JP, Grant EA, Xiong C, Berg L, Morris JC (2004) Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of the Alzheimer type. J Neuropathol Exp Neurol 63:1028–1037 Mercken M, Vandermeeren M, Lübke U, Six J, Boons J, Van de Voorde A, Martin J-J, Gheuens J (1992) Monoclonal antibodies with selective specifity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84:265–272 Munoz DG (1999) Stains for the differential diagnosis of degenerative diseases. Biotechn Histochem 74:311–320 Nagy Zs, Vatter-Bittner B, Braak H, Braak E, Yilmazer D, Schultz C, Hanke J (1997) Staging of Alzheimer-type pathology: an interrater–intrarater study. Dementia 8:248–251 Nagy S, Yilmazer-Hanke DM, Braak H, Braak E, Schultz C, Hanke J (1998) Assessment of the pathological stages of Alzheimer’s disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord 9:140–144 Nagy S, Hindley NJ, Braak H, Braak E, Yilmazer-Hanke DM, Schultz C, Barnetson L, Jobst KA, Smith AD (1999a) Relationship between clinical and radiological diagnostic criteria for Alzheimer’s disease and the extent of neuropathology as reflected by “stages”: a prospective study. Dement Geriatr Cogn Disord 10:109–114 Nagy S, Hindley NJ, Braak H, Braak E, Yilmazer-Hanke DM, Schultz C, Barnetson L, King EMF, Jobst KA, Smith AD (1999b) The progression of Alzheimer’s disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord 10:115–120 Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer’s disease. J Neuropathol Exp Neurol 58:1147–1155 Ohm TG, Müller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer’s disease-related neurofibrillary changes. Neuroscience 64:209–217 Ohm TG, Glöckner F, Distl R, Treiber-Held S, Meske V, Schönheit B (2003) Plasticity and the spread of Alzheimer’s disease-like changes. Neurochem Res 28:1715–1723 Paulus W, Bancher C, Jellinger K (1992) Interrater reliability in the neuropathologic diagnosis of Alzheimer’s disease. Neurology 42:329–332 Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006) Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63:665–672 Price JL (1997) Diagnostic criteria for Alzheimer’s disease. Neurobiol Aging 18(Suppl 4):67–70 Schönheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697–711 Schmidt ML, Lee VMY, Trojanowski JQ (1991) Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer’s disease senile plaque neurites and neuropil threads. Lab Invest 64:352–357 Smithson KG, MacVicar BA, Hatton GI (1983) Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 7:27–41 Thal DR, Holzer M, Rüb U, Waldmann G, Günzel S, Zedlick D, Schober R (2000) Alzheimer-related τ-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol 163:98–110 Thal DR, Del Tredici K, Braak H (2004) Neurodegeneration in normal brain aging and disease. SAGE 23, p 26 Tolnay M, Probst A (1999) Review: tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25:171–187 Trojanowski JQ, Shin RW, Schmidt ML, Lee VMY (1995) Relationship between plaques, tangles, and dystrophic processes in Alzheimer’s disease. Neurobiol Aging 16:335–345 Uchihara T, Nakamura A, Yamazaki M, Moris O (2001) Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 101:535–539 van Hoesen GW, Hyman BT (1990) Hippocampal formation: anatomy and the patterns of pathology in Alzheimer’s disease. Prog Brain Res 83:445–457 van Hoesen GW, Hyman BT, Damasio AR (1991) Entorhinal cortex pathology in Alzheimer’s disease. Hippocampus 1:1–8 Yamamoto T, Hirano A (1986) A comparative study of modified Bielschowsky, Bodian, and thioflavin S stains on Alzheimer’s neurofibrillary tangles. Neuropathol Appl Neurobiol 12:3–9